News
Americans taking Ozempic could be at risk of deadly heat stroke amid soaring temperatures, experts warn. The warning comes as ...
Considered a disease of middle-aged and older adults until the late 20th century, type 2 diabetes has risen markedly ...
CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...
25m
Investor's Business Daily on MSNAmgen Expands Development Plans For Highly Anticipated Obesity DrugAmgen said Monday it's expanding development plans for its weight-loss drug, MariTide, to include cardiovascular conditions ...
Novo Nordisk presented trial results from its trials evaluating the efficacy of CagriSema, another weight-loss drug. Patients ...
Novo Nordisk alleged that some telehealth entities, including Hims & Hers, used illicit semaglutide sourced from unregulated ...
Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
Novo Nordisk ends partnership with Hims & Hers over compounded Wegovy, shaking the market. See why I recommend a wait-and-see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results